CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Campbell Elizabeth S Executive Vice President | Option exercise · Non-qualified Stock Option (Right to Buy) | −3,305 | 0 | ||
| 2023-05-11 | Walgreens Boots Alliance, Inc. 10% owner | Sale | −292,792 | $170.77 | $50.0M | 33,366,388 |
| 2023-05-11 | Walgreens Boots Alliance, Inc. 10% owner | Other disposition · Forward sale contract (obligation to sell) | −918,000 | 918,000 | ||
| 2023-05-11 | Walgreens Boots Alliance, Inc. 10% owner | Other disposition · Forward sale contract (obligation to sell) | −1,836,000 | 1,836,000 | ||
| 2023-05-11 | Walgreens Boots Alliance, Inc. 10% owner | Other disposition · Forward sale contract (obligation to sell) | −918,000 | 918,000 | ||
| 2023-05-11 | Walgreens Boots Alliance, Inc. 10% owner | Other disposition · Forward sale contract (obligation to sell) | −918,000 | 918,000 | ||
| 2023-05-09 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,499 | $77.53 | $814K | 268,466 |
| 2023-05-09 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,499 | $169.52 | $1.8M | 257,967 |
| 2023-05-09 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,499 | 116,997 | ||
| 2023-05-01 | NALLY DENNIS M Director | Grant or award | +188 | $166.79 | $31K | 8,918 |
| 2023-04-11 | COLLIS STEVEN H Chairman, President & CEO | Option exercise 10b5-1 | +10,499 | $77.53 | $814K | 268,466 |
| 2023-04-11 | COLLIS STEVEN H Chairman, President & CEO | Sale 10b5-1 | −10,499 | $167.34 | $1.8M | 257,967 |
| 2023-04-11 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −10,499 | 127,496 | ||
| 2023-03-14 | COLLIS STEVEN H Chairman, President & CEO | Option exercise | +10,499 | $77.53 | $814K | 268,466 |
| 2023-03-14 | COLLIS STEVEN H Chairman, President & CEO | Sale | −10,499 | $150.00 | $1.6M | 257,967 |
| 2023-03-14 | COLLIS STEVEN H Chairman, President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) | −10,499 | 137,995 | ||
| 2023-03-09 | NALLY DENNIS M Director | Grant or award | +1,334 | 8,730 | ||
| 2023-03-09 | Miller Redonda Director | Grant or award | +1,334 | 1,562 | ||
| 2023-03-09 | McGee Henry Wadsworth III Director | Grant or award | +1,334 | 20,479 | ||
| 2023-03-09 | Kim Lorence H. Director | Grant or award | +1,334 | 1,892 |
Page 34 of 40 · 797 trades